Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Upper Extremity Implants Market, by Material
1.4.2 North America Upper Extremity Implants Market, by Type
1.4.3 North America Upper Extremity Implants Market, by End-use
1.4.4 North America Upper Extremity Implants Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Mergers & Acquisition
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals and Trials
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jun – 2023, May) Leading Players
Chapter 4. North America Upper Extremity Implants Market by Material
4.1 North America Metallic Biomaterials Market by Country
4.2 North America Ceramic Biomaterials Market by Country
4.3 North America Polymeric Biomaterials Market by Country
4.4 North America Natural Biomaterials Market by Country
Chapter 5. North America Upper Extremity Implants Market by Type
5.1 North America Shoulder Market by Country
5.2 North America Elbow Market by Country
5.3 North America Hand & Wrist Market by Country
Chapter 6. North America Upper Extremity Implants Market by End-use
6.1 North America Hospitals Market by Country
6.2 North America Clinics Market by Country
6.3 North America ASCs' Market by Country
Chapter 7. North America Upper Extremity Implants Market by Country
7.1 US Upper Extremity Implants Market
7.1.1 US Upper Extremity Implants Market by Material
7.1.2 US Upper Extremity Implants Market by Type
7.1.3 US Upper Extremity Implants Market by End-use
7.2 Canada Upper Extremity Implants Market
7.2.1 Canada Upper Extremity Implants Market by Material
7.2.2 Canada Upper Extremity Implants Market by Type
7.2.3 Canada Upper Extremity Implants Market by End-use
7.3 Mexico Upper Extremity Implants Market
7.3.1 Mexico Upper Extremity Implants Market by Material
7.3.2 Mexico Upper Extremity Implants Market by Type
7.3.3 Mexico Upper Extremity Implants Market by End-use
7.4 Rest of North America Upper Extremity Implants Market
7.4.1 Rest of North America Upper Extremity Implants Market by Material
7.4.2 Rest of North America Upper Extremity Implants Market by Type
7.4.3 Rest of North America Upper Extremity Implants Market by End-use
Chapter 8. Company Profiles
8.1 Stryker Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Geographical Expansions:
8.2 DePuy Synthes (Johnson & Johnson)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental & Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Zimmer Biomet Holdings, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Smith & Nephew PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional and Segmental Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Medtronic PLC
8.5.1 Company overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals & Trials:
8.5.5.2 Mergers & Acquisitions:
8.5.6 SWOT Analysis
8.6 Aesculap, Inc. (B. Braun Melsungen AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.7 DJO Global (Enovis Corporation)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Ossur Hf.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Acumed LLC (Colson Medical, Inc.)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.10. Arthrex, Inc.
8.10.1 Company Overview
Unique Offerings 